Chronic myeloid leukaemia Continuing PBS authority application Supporting information form (PB084)

You must lodge this form for a patient continuing PBS subsidised treatment with a tyrosine kinase inhibitor (TKI) agent for any phase of chronic myeloid leukaemia expressing the Philadelphia chromosome or the transcript BCR-ABL tyrosine kinase.


Page last updated: 5 February 2016

This information was printed Sunday 2 October 2016 from It may not include all of the relevant information on this topic. Please consider any relevant site notices at when using this material.